Background. To evaluate global and regional ventricular and atrial cardiac iodine-123 meta-iodobenzylguanidine ( 123 I-mIBG) uptake and consistency over time in healthy individuals using co-registered SPECT and CT imaging. Fifteen healthy individuals (median age 31 years [26; 41]) were included in the study. All participants underwent CT and subsequent baseline 123 I -mIBG SPECT imaging (early and late acquisition) using a dedicated cardiac solid-state gamma camera. The heart-to-mediastinum (H/M) ratio, wash out rate (WR), summed 123 I-mIBG defect score (SDS) as well as presence and patterns of left atrium (LA) discrete 123 I-mIBG uptake areas were assessed. Follow-up SPECT imaging was acquired 5-7 days after initial procedure. Results. At baseline median H/M ratio on the early and late acquisitions were 1.61 [1.57; 1.71] and 1.68 [1.65; 1.71] respectively, the WR was 22.5% [18.8; 22.8]. Areas of reduced 123 I-mIBG uptake were detected in 60% (9/15) of cases and the median SDS was 1 [0; 2]. No significant changes were observed in global and regional 123 I-mIBG cardiac uptake between baseline and follow-up studies. At baseline 36 discrete uptake areas (DUA) were identified, 16 (44%) of which (median per individual 1 [1;1]) had moderate-high confidence score (CS). 5/16, 4/16, 4/16 and 3/16 moderate-high CS DUAs were located around the left sided-, right sided- PV ostia, LA walls, right atrium (RA) or superior vena cava (SVC), respectively. At follow-up 33 DUAs were identified, 16 (48%) of which (median per individual 1 [1;1], p=0.5 vs baseline) had moderate-high CS. Moderate-high CS discrete uptake areas had generally the same location as on the baseline procedure. Conclusion. Co-registered 123 I-mIBG SPECT and CT imaging demonstrated no significant changes in the global and regional 123 I-mIBG cardiac uptake (ventricular and atrial) over a short time interval in healthy individuals.